Press Archive
Sabrina Figueiredo, PhD, MSc, joined SMHS as co-director of the Health Care Quality (HCQ) Program. Figueiredo comes to GW from McGill University in Montreal, where she served as assistant director of the physical therapy program.
Melissa Tice, PhD, recently joined SMHS as the director of the Regulatory Affairs Program. Tice comes to GW after serving as the vice president of Global Regulatory Affairs at Immunomedics Inc.
Physician-researchers at the George Washington University published a review suggesting that telehealth interventions are associated with improved obstetric outcomes.
Research from the George Washington University has found that apolipoprotein A-I binding protein restricts HIV-1 replication by targeting lipid rafts and reducing virus-cell fusion.
The outcomes for patients in their 80s who received carotid endarterectomy (CEA) surgery to reduce the risk of stroke are comparable to those of younger patients, according to a study by George Washington University (GW) researchers published in the Journal of Vascular Surgery.
Christina Puchalski, MD ’94, RESD ’97, founding director of GWish, and colleagues at GW, received international attention for their innovative training for professionals in the often-neglected area of spiritual care.
In an “Ask the Expert” article published in FOCUS: The Journal of Lifelong Learning in Psychiatry, James Griffith, MD, provides guidance on how health care professionals can connect with remote and underserved populations.
A new survey from dermatology and emergency medicine researchers at GW suggests that the dermatology community is inadequately prepared for a biological disaster and would benefit from a formal preparedness training program.
Promoting self-directed learning (SDL) can be beneficial for medical student education, and a study published in Medical Science Educator by Pritha Ghosh, MD, assistant professor of neurology at the George Washington University (GW) School of Medicine and Health Sciences, offers curriculum…
The Cutaneous Oncology Program at the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.